FDA Regs Plunged in 2017 But Other Developments Built on Trends

By Sam | March 9, 2018

Although 2017 saw significantly fewer new FDA regulations, other regulatory and enforcement activities at the agency built on existing long-term trends, according to a new report from PriceWaterhouseCoopers (PwC).
Source: Drug GMP Report

Posted in Drug GMP Report